Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment 5. Debunking Myths in the US Healthcare System
Top Ten Searches
aldosteronism contrast dialysis vitamin d bicarbonate arf amyloidosis hypocalcemia renal artery husYour Article Summary
See Latest ArticlesPeritoneal Dialysis Patients with High Effluent Fibrin Degradation Products
Advances in Peritoneal Dialysis, 10/19/09
Moriishi M et al. – In peritoneal dialysis patients with a high eFDP level, steroid therapy effectively led to a decline in eFDPs. We suggest that peritoneal dialysis patients with an eFDP level above 40 microg/mL should receive steroid therapy. Such steroid therapy may prevent EPS development, but a therapeutic effect cannot be expected in cases in which a high eFDP level has persisted for a prolonged period followed by a further increase. Thus, steroids should be administered in the earliest phase of elevation in the eFDP level. Further work is needed to determine the optimal dose of steroid.
Today in Dialysis...keeping you current
Receive free subspecialty "5-minute updates" via email
Managing diabetes in hemodialysis patients: Observations and recommendations
Cleveland Clinic Journal of Medicine, 11/04/09
Cardiovascular and Noncardiovascular Mortality Among Patients Starting Dialysis
JAMA, 10/29/09
Influenza A(H1N1)v pandemic in the dialysis population: first wave results from an international survey
Nephrology Dialysis Transplantation, 10/30/09
Article Search
Sponsor